The promoter of the human proliferating cell nuclear antigen (PCNA) gene is activated by the adenovirus oncoprotein E1A 243R in HeLa cells. To understand the eect of this oncoprotein on PCNA expression in cells that are sensitive to oncogenic transformation by adenovirus, we studied the eect of E1A 243R on PCNA promoter-directed reporter gene expression in cloned rat embryo ®broblast (CREF) and primary baby rat kidney cells. In contrast to the results obtained in HeLa cells, E1A repressed the PCNA promoter in both cell-types. Promoter analysis identi®ed a p53-responsive element that mediates E1A-induced repression. Repression required the intact N-terminus of E1A 243R, as shown by the ability of mutant E1A proteins to repress the promoter, and correlated with the p300-binding region of E1A. The adenovirus E1B 19K protein relieved repression by E1A 243R. These results reveal dual pathways for induction of this essential DNA replication factor and suggest a mechanism for oncogenic cooperativity between the E1A and E1B oncoproteins.
Introduction
Transformation by the adenovirus E1A and E1B gene products involves deregulation of the cell-cycle and loss of growth control brought about by interactions of E1A proteins with a variety of key regulatory molecules and their consequent inactivation or alteration. The E1A proteins have two transforming domains that can mediate transformation in cooperation with another oncogene such as ras or E1B (Ruley, 1983; Zerler et al., 1986) and are also required for eects on the host cell such as immortalization (Houweling et al., 1980) , induction of DNA synthesis and mitosis (Kaczmarek et al., 1986; Ruley, 1990; Moran and Mathews, 1987) . The transforming domains lie within the ®rst exon and are made up of two non-contiguous regions of the protein, one consisting of the N-terminus and conserved region 1 (CR1) and the other by conserved region 2 (CR2). These regions are common to both of the major E1A gene products, i.e., the 243 residue (243R) and the 289 residue (289R) proteins, while a third conserved region, CR3, is unique to the 289R protein and mediates its transactivation functions (Flint and Shenk, 1989; Nevins, 1989) . Despite the ability of E1A to stimulate cell proliferation, E1A induces apoptosis or programmed cell death which essentially blocks transformation and is characterized by chromatin condensation, DNA degradation, and loss of cell viability (Rao et al., 1992; White et al., 1991 White et al., , 1992 . Induction of apoptosis by E1A requires the normal functioning of the tumor suppressor protein p53 (Lowe and Ruley, 1993; Debbas and White, 1993) ; the presence of mutant p53 or E1B can block apoptosis and allow cells to become transformed (Debbas and White, 1993) .
The 243R protein, aects cellular growth and dierentiation by modulating the expression of key cellular genes (Nevins, 1992; Helin, 1993; La Thangue, 1994) . The interaction of E1A with the retinoblastoma family of proteins, via conserved regions 1 and 2, activates the transcription factor E2F which in turn induces the expression of cellular genes required for growth (Johnson et al., 1993 (Johnson et al., , 1994 . The N-terminus of E1A interacts with the p300/CBP family of transcriptional adaptor proteins that mediate the activity of a variety of transcription factors (Perkins et al., 1997; Chen and Hung, 1997; Lee et al., 1996a) .
The proliferating cell nuclear antigen (PCNA) gene encodes an essential DNA replication factor, functioning in leading and lagging strand replication as an auxiliary factor for DNA polymerase d (Prelich et al., 1987a,b; . It is among the cellular genes targeted by E1A 243R during induction of cell proliferation. PCNA synthesis is induced by agents that stimulate cell growth such as serum and growthfactors (Almendral et al., 1987; Jaskulski et al., 1988) . PCNA also functions in DNA repair (Shivji et al., 1992) and, consistent with this function, the PCNA promoter is transcriptionally activated by p53 (Shivakumar et al., 1995; Morris et al., 1996) . Growth-regulation of PCNA mRNA levels in response to serum occurs at the transcriptional and post-transcriptional levels (Chang et al., 1990) . Adenovirus infection of quiescent primary baby rat kidney (BRK) cells results in entry of cells into the growth cycle and induces PCNA expression (Zerler et al., 1987) . The E1A 12S product, 243R, is sucient for this induction although it is not known whether this response is transcriptional and/or post-transcriptional. A transcriptional response of the PCNA promoter to E1A 243R occurs in HeLa cells as observed in transient expression assays (Morris and Mathews, 1991) . Promoter sequences lying about 50 nucleotides upstream of the transcription initiation site, known as the PCNA/E1A-response element (PERE) mediate this response . Activation relies on sequences in the N-terminal region of the E1A protein that interact with p300/CBP and the retinoblastomarelated tumor suppressor protein p107 (Kannabiran et al., 1993) . Both of these proteins have been implicated in activation of the PCNA promoter, the former via stimulation through the CBP-CREB-PERE pathway (Lee and Mathews, 1997) and the latter via relief of inhibition exerted by RFX1 binding to adjacent regions of the promoter (Lee et al., 1998; Liu et al., 1999) .
Activation of an essential DNA replication factor by E1A 243R makes biological sense within the framework of E1A's proliferative eects. To date, however, most studies of the regulation of the PCNA promoter by E1A 243R were carried out in HeLa cells, which are transformed by human papillomavirus and are therefore unlikely to show a stimulation of cell proliferation in response to E1A. To examine PCNA regulation by E1A in cells that are growth-responsive to E1A, we extended investigation to cell types that display a greater degree of growth-regulation than HeLa cells and are responsive to adenovirus transformation. Surprisingly, expression directed by the PCNA promoter was repressed by E1A 243R in both of the non-transformed cell types used in this study, primary baby rat kidney (BRK) cells and an established line of cloned rat embryo ®broblasts (CREF). Promoter sequences upstream of the transcriptional initiation site were found to be required for the response. This region of the promoter has a p53-consensus sequence located between nucleotides 7217 and 7237, which binds p53 resulting in promoter activation. Substitution of the p53 site within the PCNA promoter by a heterologous p53-binding site restored E1A-mediated repression as well as p53-induced activation of the promoter. Repression was speci®c for the N-terminus of E1A and correlated with its p300 interaction site as indicated by the ability of various E1A mutant expression constructs to repress the promoter.
Results
The 243R oncoprotein represses the PCNA promoter in rodent cells
Following the approach taken previously with HeLa cells (Morris and Mathews, 1991) , BRK cells were transfected with a plasmid that expresses E1A 243R, namely pCMV12S, or with pCMV12S.FS (which encodes a non-functional fragment of the E1A protein), together with reporter constructs containing the CAT gene under the direction of various regions of the human PCNA promoter (diagrammed in Figure  1c ). Figure 1a shows the CAT activity generated by the PCNA-CAT constructs, standardized to the activity obtained with the 71265 to +62 PCNA-CAT construct in the presence of the transfection control plasmid, pCMV12S.FS. In contrast to the results obtained with HeLa cells, E1A 243R repressed expression from the 71265 to +62 PCNA-CAT construct in BRK cells about ®vefold (Figure 1a ).
Serial deletions of the promoter to 7234 had essentially no eect on promoter activity or repression by E1A 243R, but deletion of sequences to 7213 or beyond both reduced promoter activity and relieved E1A-induced repression. To further de®ne the sequences required for repression, sequences upstream of 747 were deleted to produce dl-190/-47 and dl-112/-47, or substituted to produce sub-66/-47. As shown in Figure 1a , all three of these constructs were repressed by E1A indicating that sequences between 7190 and 747 are not required for repression (although sequences between 7190 and 7112 are needed for full promoter activity). Removal of the ATF consensus site at about 750 which is part of the E1A-response element in HeLa cells, or of transcribed PCNA sequences (in constructs 71256 to +62 ATFD and 7560 dl 72 to +62, respectively) did not aect repression by E1A. These data suggest that the region of the promoter between 7234 and 7213 mediates repression by E1A.
The unexpected inhibitory response of the PCNA promoter to E1A 243R in BRK cells may be peculiar to primary cells, or, since BRK cells are a heterogeneous mixture of cell types, might pertain to a subpopulation of cells that are preferentially transfected. To address these possibilities, the response of the PCNA promoter to E1A 243R was assayed in CREF cells, a rat ®broblast cell-line that can be transformed by adenovirus (Fisher et al., 1982) . In dose curve experiments, co-transfection of increasing amounts of pCMV12S progressively repressed CAT synthesis from 71265 to +62 PCNA-CAT, reaching a maximal threefold repression at 50.25 mg pCMV12S per 6 cm plate (data not shown). As in BRK cells, removal of promoter sequences between 7234 and 7213 resulted in loss of repression ( Figure 1b ). The magnitude of E1A-mediated repression in CREF cells was somewhat less than that obtained with BRK cells (Figure 1a) . A lesser degree of repression would be manifested if E1A 243R also activated the promoter in CREF cells through the 750 element that is operative in HeLa cells (Morris and Mathews, 1991; . Consistent with this explanation, a small but reproducible degree of activation was observed with the shorter promoter constructs (downstream of 7213; Figure 1b ). In contrast, no such activation was seen with these constructs in BRK cells ( Figure 1a ).
Repression by E1A is mediated by the p53-binding site
Previous studies demonstrated that the PCNA promoter contains a p53-consensus site between 7217 and 7236 that mediates p53-dependent activation of the promoter (Morris et al., 1996) . The data presented above suggest that E1A 243R represses transcriptional activation of the PCNA promoter via these sequences and, by implication, via p53. Consistent with this inference, E1A 243R does not repress the PCNA promoter in HeLa cells (Morris and Mathews, 1991; Labrie et al., 1993) which express the HPV E6 oncoprotein that targets p53 for degradation.
To test whether the p53-binding site is indeed the target for E1A-mediated repression, we employed RGC213 (Figure 2a ), a construct that has a heterologous p53-binding site from the ribosomal gene cluster in place of the native p53 binding site (Morris et al., Figure 2b ) while replacement of the native site with the heterologous p53-binding site in RGC213 restored E1A-induced repression. These results strongly suggest that E1A is repressing p53-mediated activation of the promoter.
Repression of p53-mediated transcriptional activation of the PCNA promoter requires sequences in the N-terminus of E1A
To correlate repression of the PCNA promoter by E1A 243R with its other functions, we studied the eect of various E1A mutant constructs on PCNA-CAT expression in CREF cells (Figure 3) . In HeLa cells, these constructs express E1A proteins at levels comparable to that of wild-type E1A 243R (Kannabiran et al., 1993) . Figure 3 compares the repression activities of mutant E1A proteins to that of the wildtype 243R which is taken as 100%. Mutations that impair conserved region 2 functions, such as binding to p105Rb (pm124), or p105Rb, p107/cyclin A and p130 (pm47/pm124, dl 120 ± 140), did not impair repression of PCNA-CAT activity. A deletion of the nonconserved spacer region between CR1 and CR2 (dl86 ± 120) similarly had no eect on repression. In contrast, repression was attenuated by deletions that involved the N-terminus and CR1. Deletion of amino acids 2 ± 36 (dl 2 ± 36) resulted in substantial loss of repression; large deletions aecting the entire CR1 (dl30 ± 85) or the N-terminus and CR1 together (dl 2 ± 85) were also signi®cantly impaired in their repression action; and E1A proteins with smaller deletions of the N-terminus (dl 2 ± 13) or of CR1 (dl 60 ± 85) were partially defective. The three repression-defective mutants, dl 2 ± 36, dl 2 ± 13 and dl 60 ± 85, are negative for interaction with p300 by co-immunoprecipitation but bind all other known proteins that interact with E1A (Whyte et al., 1989; Stein et al., 1990) . These three mutants are not equally defective for PCNA-CAT repression, however; a correlation might exist between p300 binding and repression of PCNA-CAT expression if the in vivo assay detects small dierences in anity that are not evident in an immunoprecipitation.
The adenovirus E1B 19K protein relieves E1A-induced repression by E1A 243R
The E1A-induced repression of the PCNA promoter in BRK cells documented here in transient expression assays stands in contrast with the observation that adenovirus infection of BRK cells activates PCNA gene expression by an E1A-dependent mechanism (Zerler et al., 1986) . Expression of the PCNA gene is regulated post-transcriptionally (Chang et al., 1990) , as well as at the transcriptional level, and post-transcriptional induction of PCNA mRNA might provide a mechanism that could account for this apparent inconsistency. Alternatively, activation of the PCNA gene during viral infection could be due to the combined eects of E1A and other viral gene products. To examine this possibility, BRK cells were transfected with the 71265 to +62 PCNA-CAT plasmid and then infected with adenoviruses that express the large (13S-E1A 289R) or small (12S-E1A 243R) E1A products or fail to express E1A (dl 312). At 16 and 24 h post-infection, the levels of the endogenous rat PCNA mRNA, the transientlyexpressed human PCNA-CAT mRNA, and the virally-expressed E1A mRNAs were examined by RNase protection analysis (Figure 4 ). In agreement with previous observations (Zerler et al., 1987) , cells infected with viruses that express either of the E1A products contained higher levels of the cellular rat PCNA mRNA than cells infected with dl 312. In contrast to the co-transfection assays, E1A expression during viral infection activated expression from the transfected human PCNA-CAT construct to a slight extent. The failure of the virus to repress PCNA-CAT expression suggests that other viral gene products may prevent repression of the PCNA promoter by E1A. The large increase in the levels of the rat PCNA mRNA was not matched by a similar increase in the level of PCNA-CAT mRNA: this observation suggests that PCNA mRNA levels may be subject to posttranscriptional regulation during adenovirus infection, or that sequences in the PCNA gene outside those present in the PCNA-CAT construct can mediate transcriptional activation of the gene by the virus. The adenovirus E1B gene cooperates with the E1A gene to transform primary cells in culture (Ruley, 1990) . In addition, many of the toxic eects of E1A expression in cells are overcome by co-expression of the E1B gene (White et al., 1991; White and Stillman, 1987; Debbas and White, 1993; Lowe and Ruley, 1993) . Essential transforming functions of both the E1B 19K and the E1B 55K adenovirus oncoproteins Figure 3 Repression activity of E1A 243R mutants. The E1A 243R wild-type and mutants, shown schematically, were assayed for their ability to repress expression of the 71265 ± +62 PCNA-CAT construct in CREF cells. Numbers at the top indicate aminoacid residues,`X' indicates a point mutation, and the hatched portion in the case of 12S.FS indicates the frameshifted region of the protein. CAT activities were determined and corrected for b-galactosidase activity. Wild-type E1A 243R repressed PCNA-CAT expression about fourfold relative to the control (pCMV12S.FS) and is taken as 100% repression Figure 4 Activation of the PCNA promoter by adenovirus-born E1A. BRK cells were transfected with 71265 ± +62 PCNA-CAT and infected 12 h later with recombinant adenoviruses that did not express E1A (dl 312), or expressed the 12S and 13S products individually. Cytoplasmic RNA was prepared at 16 and 24 h post-infection and was analysed by RNase protection with probes for each of the indicated mRNAs Figure 5 Eects of E1B products on E1A-mediated repression of PCNA-CAT. PCNA-CAT constructs shown were co-transfected into BRK cells with the E1A 243R expression plasmid (pCMV12S) alone or in combination with plasmids expressing either the E1B 19K (pCMV19K) or the 55K (pCMV55K) gene products (0.5 mg each). Control indicates promoter activity in the presence of pCMV12S.FS. This plasmid was added at the appropriate amount to give each transfection a total of 1 mg of CMV expression vector. Results are expressed as CAT activity averaged from two independent transfections done in duplicate E1A represses PCNA expression C Kannabiran et al appear to be related to their ability to antagonize the activities of wild-type p53 (White and Cipriani, 1990; White et al., 1991; Barker and Berk, 1987) . Therefore the E1B proteins seemed likely candidates for viral gene products that could relieve E1A 243R-induced repression of the PCNA promoter. To test this inference, the E1B 55K and the E1B 19K products were assayed individually for their ability to overcome E1A-induced repression of the PCNA promoter in BRK cells. As expected from the data shown in Figure  2b , E1A 243R repressed PCNA-CAT expression from the 7249 and the RGC213 PCNA-CAT constructs in BRK cells, whereas the 7213PCNA-CAT construct was unaected ( Figure 5 ). Co-expression of the 55K protein had no signi®cant eect on the E1A response but co-transfection of an E1B19K expression vector releived E1A-mediated repression ( Figure 5 ). The 19K protein elevated expression from all constructs, irrespective of the presence of the p53-consensus. These observations are consistent with previous studies showing that the 19K protein elevates geneexpression from a number of cellular and viral genes (Hermann and Mathews, 1989) .
Discussion
Our studies on the regulation of the PCNA promoter by E1A show that the response is cell-type speci®c and ascribe the dierences to the inhibition by E1A of p53-mediated promoter activation. In HeLa cells, derived from a cervical carcinoma, the promoter is transactivated by the E1A 243R protein (Morris and Mathews, 1991 (Karuppayil et al., 1998) . Examination of the basal activity of the PCNA promoter in BRK and CREF cells, shows that the p53-binding element together with functional p53 protein confers a signi®cant activation of the promoter in the absence of E1A (Morris et al., 1996) ; in these cells, removal of the ATF site or adjacent regulatory elements from the promoter did not aect promoter activity as much as removal of the p53 consensus (Figure 1 ). On the other hand, in HeLa cells, which have low eective levels of p53, the contribution of the ATF/PERE sites to promoter activity is of greater magnitude than that of the p53-binding element (Morris and Mathews, 1991; Morris et al., 1996) . Evidently, in cells with normal levels of p53, this is the chief determinant of PCNA promoter activity and E1A dampens its stimulatory function.
Why do p53 and E1A 243R activate the PCNA promoter when present separately, but in combination give rise to reduced activation? Although the mechanism is not fully understood, it is likely that CBP and/or p300 play a central role. In a number of systems, these proteins serve as co-activators, mediating activation by sequence-speci®c DNA-binding factors such as CREB and p53 (Gu et al., 1997; Lill et al., 1997; Goldman et al., 1997) ; on the other hand, p300 can also mediate repression (Lee et al., 1995) . In the PCNA gene, CBP mediates promoter activation by E1A in HeLa cells through a CREB-CBP complex (Lee and Mathews, 1997) , and the same appears to hold true in p53-minus SAOS-2 cells (Karuppayil et al., 1998) . Stimulation by E1A in HeLa cells is due, at least in part, to the relief of repression by RFX1 mediated by p107 (Lee et al., 1998; Liu et al., 1999) . Involvement of the N-terminal region of E1A suggests that p300 is a target of E1A action in BRK and CREF cells, as shown here, and a similar conclusion has been drawn from experiments with p53-transfected SAOS-2 cells (Karuppayil et al., 1998) . E1A disrupts p53-mediated activation through its p300-binding region (Lill et al., 1997; Somasundaram and El-Deiry, 1997) , and was recently shown to inhibit the histone acetyltransferase (HAT) activity of p300 (Hamamori et al., 1999) . Thus, one model would attribute the individual stimulatory eects of p53 and E1A to their separate interactions with p300 and CBP, and the inhibitory action of E1A in the presence of p53 would be due to perturbation of the p53-p300 complex Figure 6 Dierential eects of E1A 243R on the PCNA promoter. The diagram indicates three mechanisms regulating transcriptional initiation at the PCNA promoter (represented by the horizontal line). Stimulation and inhibition by E1A are represented by large and small arrows beginning at +1. (a) p53 binds at the site between 7234 and 7213, recruits p300, and stimulates transcription; stimulation by p53 is blocked by E1A 243R which disrupts the p53-p300 complex. (b) CREB binds to the ATF-1 site (752 to 745) in the PERE, recruits CBP and stimulates transcription; this action is enhanced by E1A 243R (indicated by the triple arrow shaft). (c) RFX1 binds to a consensus site between 754 and 741 (an interaction that is also in¯uenced by upstream nucleotides) with a negative eect on transcription that is relieved by E1A 243R, probably via its interaction with p107. See text for details and citations by E1A (Figure 6 ). Alternatively, it is possible that p300 and CBP dier in their responses to E1A 243R: for example, the HAT activity of CBP is reportedly stimulated by E1A whereas that of p300 is inhibited (Hamamori et al., 1999) . On this basis, E1A would be expected to lessen the p300 HAT activity recruited by p53, but to enhance the CBP HAT activity recruited by CREB, resulting in opposite eects on promoter activity. It should be noted that the requirement for the PERE in the eects of p53 is questionable. Although dierent results were seen in SAOS-2 cells in the presence of p53 (Karuppayil et al., 1998) , mutation of the ATF-1/CREB site had little eect on the basal activity of the PCNA promoter or on its response to E1A in BRK or CREF cells (Figure 1) . Therefore it appears that p300 and CBP can be recruited to the PCNA promoter independently by p53 and CREB.
As an extension of this view, we propose that p300 serves as the co-activator controlling the PCNA gene in circumstances of DNA damage and dierentiation while CBP functions in growth conditions. p300 acts in concert with p53 in activating p53-responsive genes and functions as an inducer of cell-cycle arrest in response to DNA damage and terminal dierentiation (Missero et al., 1995; Perkins et al., 1997) . DNA damage results in p53-induced G1-arrest, wherein p53 prevents cells from entering S phase by transcriptionally activating cell-cycle inhibitors such as p21/CIP1 (Harper et al., 1993; Xiong et al., 1993) and promotes DNA repair thus maintaining the integrity of the genome. The latter associates directly with PCNA and inhibits its replication activity while leaving the PCNAdependent repair process intact (Li et al., 1994; Waga et al., 1994) . Inhibition of p53 transactivation is part of the process by which E1A deregulates the cell-cycle, thus abolishing G1-arrest response (Steegenga et al., 1996) . In view of the requirement for PCNA in DNA synthesis and repair, it is signi®cant that p53 controls PCNA expression in cell-types that show some degree of growth-regulation. PCNA transcription is activated by low levels of p53 and repressed by high levels (Morris et al., 1996; Shivakumar et al., 1995) . Regulation of p53 levels by E1A might contribute to a decrease in p53-mediated activation of PCNA expression since E1A expression increases cellular p53 levels in BRK cells and rat embryo ®broblasts, and induces apoptosis in both cell types (Debbas and White, 1993; Lowe and Ruley, 1993) . Stabilization of p53 requires the N-terminus of E1A 243R (Querido et al., 1997) . Induction of apoptosis by p53 may be linked to its ability to repress transcription (Shen and Shenk, 1994) and downregulation of PCNA expression could be part of the cellular response leading to apoptosis.
In adenovirus infection, when both the E1A and E1B genes are expressed, the expression of PCNA-CAT was stimulated (Figure 4) . The increase in PCNA promoter activity is apparently due to activation mediated by the E1B 19K protein ( Figure 5 ) although this eect was not p53-speci®c. Transformation requires both E1B and E1A genes. Both the E1B gene products antagonize p53 function and independently block apoptosis induced by E1A (Sabbatini et al., 1995; Debbas and White, 1993; Lowe and Ruley, 1993) thereby counteracting the cellular response to E1A. Thus it is likely that PCNA expression is maintained at an elevated level by the E1B 19K protein in cells undergoing adenovirus-mediated transformation. Although the E1B 19K protein activated the PCNA promoter regardless of whether the p53-binding site was present, inactivation of p53 can result in a loss of E1A-mediated repression since E1A does not repress the PCNA promoter in HeLa cells which lack normal levels of functional p53.
These studies have uncovered a novel aspect of the regulation of the PCNA promoter by E1A 243R. Dierential regulation of promoter activity by E1A in dierent cell-types and promoter con®gurations has been described in other studies DeGroot et al., 1991; Oringa et al., 1990; Hagmeyer et al., 1993; Lee et al., 1996b) . The present study reveals that p53 status of the cells is a key determinant in the mode of regulation of PCNA by E1A 243R, emphasizing the multiplicity of pathways that this viral oncoprotein has evolved to modulate the expression of genes that regulate cellular proliferation and differentiation in varied physiological contexts.
Materials and methods

Plasmids
The PCNA-CAT constructs including the 71265 to +62 PCNA-CAT and mutated versions thereof have been described earlier (Morris and Mathews, 1990) . Additional PCNA-CAT constructs were prepared by digestion with the appropriate restriction enzyme and cloning the desired restriction fragment between the XhoI and HindIII sites of pBACAT. The sequences of the upstream border of these additional constructs from the common XhoI site are as follows (with PCNA promoter sequences in uppercase): 7234 ctcgaTATGCC; 7213 ctcgaggGGCCGG; 7203 ctcgAGGAGT.
In each of the above, the downstream border was formed at the NruI site (+62, previously +60; Mathews, 1990, 1991) of the PCNA promoter with the addition of a HindIII linker. Plasmid 71265 dl-190/-47 has PCNA promoter sequences from 7190 to 747 replaced by a 19 nucleotide sequence derived from pBACAT to produce a construct with the sequence AAGAGGatcttcgagacgataagctTCGCAA, where uppercase letters denote PCNA promoter sequence and lowercase letters denote pBACATderived sequence. The RGC213 PCNA-CAT construct was prepared by inserting wild-type p53-binding sequences from the ribosomal gene cluster (RGC) into a XhoI site upstream of the 7213 PCNA-CAT construct, giving the sequence ctcgagTTGCCTGGACTTAGCCTGGCCTTGCCTTTTCtcgaggGGCCGG with the RGC sequence underlined. Plasmids that express various E1 products and mutants thereof were described previously (Morris and Mathews, 1990; Kannabiran et al., 1993) .
Transfection assays
CREF cells were obtained from S Silverstein, Columbia University. Monolayer cultures were grown in Dulbecco's modi®ed Eagle's medium with 5% fetal bovine serum and 100 mg penicillin and streptomycin per ml. Cells at about 50 ± 60% con¯uence were transfected in 60 mm dishes by the DEAE-dextran method. Each transfection mix contained 30 ml of a 10 mg/ml stock solution of DEAE-dextran, 5 mg of the reporter, and, unless otherwise indicated, 0.5 mg pCMV12S or pCMV12S.FS, in a ®nal volume of 600 ml of phosphate-buered saline (PBS). Medium was removed from the plates, the transfection mix was added, and the plates were returned to the 378C incubator for 30 min. Plates were gently rocked occasionally to ensure that the solution was evenly distributed. Fresh medium was added (5 ml per 6 cm dish), and the cells were DMSO-shocked 6 h later by incubating with medium containing 10% DMSO for 2.5 min, followed by a rinse with PBS and the addition of fresh medium. The cells were harvested 48 h after transfection and assayed for CAT (Gorman et al., 1982; Herrman et al., 1987) and b-galactosidase activities (Herbomel et al., 1984) . Baby rat kidney (BRK) cells, prepared as previously described from 6 day-old rats, were transfected in 6 cm dishes by the calcium phosphate co-precipitation method. Cells were harvested at 48 h post-transfection for determination of CAT activity.
Infections and RNA analysis BRK cells transfected with 5 mg of the PCNA-CAT reporter were infected 12 h later (8 h after glycerol shock) with adenovirus constructs expressing either E1A 243R (12S virus) or 289R (13S virus) at a multiplicity (MOI) of 20. Cells were harvested and total cytoplasmic RNA was prepared at 16 and 24 h post-infection (Morris and Mathews, 1990) . The RNA recovered from 6 cm plates was analysed by RNase protection with three dierent probes simultaneously: a *500 bp fragment from a rat PCNA cDNA clone (pCR-1; (Matsumoto et al., 1987) speci®c for the 3' portion of the rat PCNA mRNA; a probe speci®c for the 5' portion of the mRNA expressed from the transfected human PCNA-CAT plasmid; and a probe speci®c for E1A mRNA (Morris et al., 1994) .
